Physician
Nephrology
Dr. Harvey D. Humes, MD
|
|
Give Review
Dr. Harvey D. Humes practices Nephrology. He went to University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a one of the best medicals schools. University of California San Francisco School of Medicine has a rank of 3 in research and a 3 in primary care He has 1 awards "Whos Who in Medicine and Healthcare". Harvey D. Humes, MD is a published doctor. He published 100 publications, including: 'Limiting acute renal failure.' Harvey Humes is registered with Medicare.
Publications
- A bio-artificial Renal epithelial cell system conveys survival advantage in a porcine model of septic shock.
- The bioartificial Kidney.
- The effect of the selective cytopheretic device on Acute kidney injury outcomes in the intensive care unit: a multicenter pilot study.
- The bioartificial Kidney: current status and future promise.
- Selective cytopheretic inhibitory device With regional citrate anticoagulation and portable sorbent dialysis.
- Implanted Renal replacement for end-stage Renal disease.
- A biomimetic membrane device that modulates the excessive inflammatory response to sepsis.
- The effects of a novel therapeutic device on Acute kidney injury outcomes in the intensive care unit: a pilot study.
- Cell therapy, advanced materials, and new approaches to Acute kidney injury.
- Stem cell technology for the treatment of Acute and chronic renal failure.
- A microfluidic bioreactor With integrated transepithelial electrical resistance (TEER) measurement electrodes for evaluation of renal epithelial cells.
- A selective cytopheretic inhibitory device to treat the immunological dysregulation of Acute and chronic renal failure.
- Renal cell therapy and beyond.
- New insights into mechanisms of glomerular permselectivity.
- The bioartificial kidney in the treatment of Acute kidney injury.
- Cell therapy in Kidney failure.
- Dialysis dosing in critically ill patients with Acute kidney injury.
- The bioartificial kidney and bioengineered membranes in Acute kidney injury.
- Efficacy and safety of renal tubule cell therapy for Acute renal failure.
- Development of continuous implantable Renal replacement: past and future.
- Tissue engineering of an implantable bioartificial hemofilter.
- Dialysis and nanotechnology: now, 10 years, or never?
- Kidney epithelial cells.
- Bioartificial kidney in the treatment of Acute renal failure associated with sepsis.
- Differentiated growth of human Renal tubule cells on thin-film and nanostructured materials.
- The future of hemodialysis membranes.
- Stem cells: the next therapeutic frontier.
- Stem cell approaches for the treatment of renal Failure.
- Translational medicine and the National Institutes of Health road map: steep grades and tortuous curves.
- The future of renal support: high-flux dialysis to bioartificial Kidneys.
- Is acetylcysteine effective in preventing contrast-related Nephropathy? A meta-analysis.
- Rare incorporation of bone marrow-derived cells into Kidney after folic acid-induced injury.
- Initial clinical results of the bioartificial kidney containing human cells in ICU patients with Acute renal failure.
- BKV and SV40 infection of human Kidney tubular epithelial cells in vitro.
- Advances in cell therapy for renal Failure.
- Renal cell therapy in the treatment of patients with Acute and chronic renal failure.
- Cell therapy of renal Failure.
- Cell therapy with a tissue-engineered Kidney reduces the multiple-organ consequences of septic shock.
- Cell therapy: leveraging nature's therapeutic potential.
- Renal cell therapy is associated with dynamic and individualized responses in patients with Acute renal failure.
- Bioartificial Kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals.
- The bioartificial kidney in the treatment of Acute renal failure.
- Metabolic replacement of Kidney function in uremic animals with a bioartificial Kidney containing human cells.
- Bioartificial Kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals.
- The role of a bioengineered artificial Kidney in renal failure.
- Bioartificial organ support for hepatic, renal, and hematologic Failure.
- Insights into ototoxicity. Analogies to nephrotoxicity.
- Bioartificial Kidney for full renal replacement therapy.
- Design engineering of a bioartificial Renal tubule cell therapy device.
- Tissue engineering of a bioartificial Renal tubule assist device: in vitro transport and metabolic characteristics.
- Replacement of renal function in uremic animals with a tissue-engineered Kidney.
- Structure and function of cell adhesion molecules.
- Limiting Acute renal failure.
- Cell therapy and tissue engineering for Renal replacement therapy.
- Tissue engineering of a bioartificial Renal tubule.
- Acute renal failure: growth factors, cell therapy, and gene therapy.
- The bioartificial renal tubule assist device to enhance CRRT in Acute renal failure.
- Transforming growth factor-beta 1 regulates the expression of Pax-2, a developmental control gene, in Renal tubule cells.
- Prospects for a bioartificial Kidney.
- Acute renal failure--the promise of new therapies.
- The bioartificial renal tubule: prospects to improve supportive care in Acute renal failure.
- Application of gene and cell therapies in the tissue engineering of a bioartificial Kidney.
- Tissue engineering of a bioartificial Kidney: a universal donor organ.
- Tubulogenesis from isolated single cells of adult mammalian Kidney: clonal analysis with a recombinant retrovirus.
- Acute renal failure: prevailing challenges and prospects for the future.
- Role of proteoglycans and cytoskeleton in the effects of TGF-beta 1 on Renal proximal tubule cells.
- Potential molecular therapy for Acute renal failure.
- Acute renal failure: directed therapy to enhance renal tubular regeneration.
- Cellular and molecular aspects of renal repair in Acute renal failure.
- Cellular and molecular basis of renal repair in Acute renal failure.
- Carbon-11-acetate PET imaging in Renal disease.
- Renal tubule cell repair following Acute renal injury.
- Mechanisms of gentamicin-induced dysfunction of Renal cortical mitochondria. II. Effects on mitochondrial monovalent cation transport.
- Mechanisms of gentamicin-induced dysfunction of Renal cortical mitochondria. I. Effects on mitochondrial respiration.
- Interaction between antidiuretic and parathyroid hormones on urine concentration.
- Glomerular dynamics in rats With hereditary hydronephrosis.
- Inhibitory effects of gentamicin on Renal mitochondrial oxidative phosphorylation.
- Alterations of mitochondrial respiration induced by aminoglycoside antibiotics.
- Reversible Renal insufficiency in multiple myeloma.
- Identification of the aminoglycoside binding site in rat Renal brush border membranes.
- Clinical and pathophysiologic aspects of aminoglycoside nephrotoxicity.
- Alterations in Renal cortical phospholipid content induced by gentamicin: time course, specificity, and subcellular localization.
- The effect of gentamicin on Calcium uptake by renal mitochondria.
- Ionophore A23187 induced reductions in toad urinary bladder epithelial cell oxidative phosphorylation and viability: implications for A23187 related declines in epithe...
- Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary Calcium supplementation protects against gentamicin nephrotoxicity.
- Characterization of Ca2+ transport in rat Renal brush-border membranes and its modulation by phosphatidic acid.
- Mitochondrial bioenergetics during the initiation of mercuric chloride-induced Renal injury. II. Functional alterations of Renal cortical mitochondria isolated after m...
- Mitochondrial bioenergetics during the initiation of mercuric chloride-induced Renal injury. I. Direct effects of in vitro mercuric chloride on Renal mitochondrial fun...
- The effect of gentamicin on antidiuretic hormone-stimulated osmotic water flow in the toad urinary bladder.
- Effect of verapamil on the hydroosmotic response to antidiuretic hormone in toad urinary bladder.
- Alterations of renal tubular cell metabolism in Acute renal failure.
- Alterations in Renal cortex cation homeostasis during mercuric chloride and gentamicin nephrotoxicity.
- Acute renal failure induced by diethylaminoethyl dextran: importance of cationic charge.
- Distribution of gentamicin among subcellular fractions from rat Renal cortex.
- Calcium transport and inner mitochondrial membrane damage in renal cortical mitochondria.
- Increases of cell ATP produced by exogenous adenine nucleotides in isolated rabbit Kidney tubules.
- Pathogenetic mechanisms of nephrotoxicity: insights into cyclosporine nephrotoxicity.
- Pathogenesis of cyclosporine nephrotoxicity.
- Direct toxic effect of the radiocontrast agent diatrizoate on Renal proximal tubule cells.
Schools
University Of California San Francisco School Of Medicine
Moffit Hospital Uc San Francisco
Peter Bent Hospital
University Of Pennsylvania
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
- Choice Plus POS II
- Blue Cross Blue Shield
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Geisinger Health Plan
- GEHA
- Health Alliance
- Preferred PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Priority PPO
- Tricare
- Choice Plus POS
- Options PPO
Awards
- Whos Who in Medicine and Healthcare
Education
-
Brigham and Women's Hospital -
University of Pennsylvania Health System -
UCSF -
University of California San Francisco School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386734119 |
| Last Name Of The Provider | HUMES |
| First Name Of The Provider | HARVEY |
| View All |
Similar Doctors
|
|
Dr. Chen H. Hsu, MD |
|
|
Dr. Akinlolu O. Ojo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia C. Tsui, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raghav Wusirika, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Crystal A. Gadegbeku, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fu L. Luan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Milagros D. Samaniego-Picota, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Subramaniam Pennathur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie A. Wright, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James P. Smith, MD |
|
|
Yan Yang, MB BS |